PATENT CLAIM ANALYSIS

Application Number: 16043725
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "059000"]

Abstract:
The disclosure provides cosmetic and therapeutic compositions of alpha-adrenergic agents. Compositions of the disclosure may be used for topical, transdermal or parenteral administration to the eye or eyelid. The compositions of the disclosure may be used cosmetically to improve the appearance of the eye or therapeutically to treat ptosis.

Claim (Index 78):
A method for increasing the vertical separation of the upper and lower eyelids of an eye of a subject, comprising administering a composition comprising an effective amount of an alpha-adrenergic agent to the exterior surface of the eyelid of the eye of the subject.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.65625
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13270577', '14625099', '13408364', '15946709', '15051654']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7065535035948245
- 35 USC 102 Novelty (BERT): 0.5103242412150563
- Combined Prediction Score: 0.6869305773568477
- Mean Citation Score: 207.44380800000005
- Max Citation Score: 234.90898
- Similarity Product: 136.3006768431616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test